Lumax

Manufactured by Biotronik

Sourced in United States

The Lumax is a cardiac diagnostic device manufactured by Biotronik. It is designed to monitor and record cardiac activity. The core function of the Lumax is to collect and analyze data related to the electrical activity of the heart.

Automatically generated - may contain errors

Lab products found in correlation

Cognis, by Boston Scientific (2 mentions) Insync 3, by Medtronic (2 mentions)

2 protocols using lumax

Cardiac Resynchronization Therapy Implantation

Check if the same lab product or an alternative is used in the 5 most similar protocols

All patients underwent successful CRT-P (pacemaker only CRT) or CRT-D (CRT with implantable cardioverter defibrillator) implantation. The right atrial and right ventricular leads were positioned in the right appendage and mid interventricular septum or in the RV apex. Left ventricular lead positioning was performed under guidance of venography, and when accessible lateral or postero-lateral cardiac veins were chosen. Implanted devices included Contak Renewal (Guidant Corp., Arden Hills, MN, USA), Cognis (Boston Scientific USA), Stratos, Lumax (Biotronik, Berlin, Germany) and Insync III (Medtronic Inc., Minneapolis, MN, USA). We implanted CRT-Ds to 46% of the patients. CRT-D was indicated in case of those patients who suffered previously documented ventricular arrhythmias and whenever it was indicated by the referring physician [14 (link)].

Nagy V.K., Széplaki G., Apor A., Kutyifa V., Kovács A., Kosztin A., Becker D., Boros A.M., Gellér L, & Merkely B. (2015). Role of Right Ventricular Global Longitudinal Strain in Predicting Early and Long-Term Mortality in Cardiac Resynchronization Therapy Patients. PLoS ONE, 10(12), e0143907.

+ Open protocol

+ Expand

Cardiac Resynchronization Therapy Implantation

Check if the same lab product or an alternative is used in the 5 most similar protocols

Cardiac resynchronization therapy was implanted successfully in all patients without major complications. The right atrial (where appropriate) and right ventricular (RV) leads were positioned in the right appendage and mid-interventricular septum or in the RV apex, respectively. Coronary sinus venography was used for LV lead positioning. Lateral and posterolateral cardiac veins were preferred for LV lead implantation. Implanted devices were Contak Renewal (Guidant Corp., Arden Hills, MN, USA). Cognis (Boston Scientific, Marlborough, MA, USA), Stratos, Lumax (Biotronik, Berlin, Germany), and Insync III (Medtronic Inc., Minneapolis, MN, USA).

Nagy K.V., Széplaki G., Perge P., Boros A.M., Kosztin A., Apor A., Molnár L., Szilágyi S., Tahin T., Zima E., Kutyifa V., Gellér L, & Merkely B. (2017). Quality of life measured with EuroQol-five dimensions questionnaire predicts long-term mortality, response, and reverse remodelling in cardiac resynchronization therapy patients. Europace, 20(9), 1506-1512.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!